APA (7th ed.) Citation

Chen, N., Qian, J., Chen, J., Yu, X., Mei, C., Hao, C., . . . Valone, F. H. (2017). Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China. Nephrology, dialysis, transplantation, 32(8), 1373-1386. https://doi.org/10.1093/ndt/gfx011

Chicago Style (17th ed.) Citation

Chen, Nan, et al. "Phase 2 Studies of Oral Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor FG-4592 for Treatment of Anemia in China." Nephrology, Dialysis, Transplantation 32, no. 8 (2017): 1373-1386. https://doi.org/10.1093/ndt/gfx011.

MLA (9th ed.) Citation

Chen, Nan, et al. "Phase 2 Studies of Oral Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor FG-4592 for Treatment of Anemia in China." Nephrology, Dialysis, Transplantation, vol. 32, no. 8, 2017, pp. 1373-1386, https://doi.org/10.1093/ndt/gfx011.